SCHEMBL7564076

SCHEMBL7564076

N#CC1(c2ccccc2)CCN(CC(O)COc2ccc(-c3occ4cc(F)ccc34)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.43
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CHRNA7 P36544 1/20 0.40
HTR1A P08908 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ABCB1 P08183 2/20 0.39
TSHR P16473 1/20 0.39
USP2 O75604 1/20 0.39
CACNA1G O43497 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7572390 0.82 KDM4E (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL1382258 0.82 ATM (0.56) KDM4EKMT2AABCB1TSHR
SCHEMBL5365487 0.82 HTR2A (0.47) PKMALDH1A1KDM4EMEN1KMT2A
SCHEMBL5366314 0.82 HTR2A (0.47) PKMALDH1A1KDM4EMEN1KMT2A
SCHEMBL5365483 0.82 HTR2A (0.47) PKMALDH1A1KDM4EMEN1KMT2A
SCHEMBL7569775 0.82 HTR1A (0.53) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL7572169 0.81 PKM (0.57) PKMALDH1A1KDM4EKMT2AL3MBTL1
SCHEMBL1381988 0.81 CHRNA7 (0.49) PKMCHRNA7HTR1ATSHRUSP2
SCHEMBL1383323 0.81 CHRNA7 (0.49) PKMCHRNA7HTR1ATSHRUSP2
SCHEMBL7573958 0.81 CACNA1G (0.48) KMT2AHTR1ACACNA1G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP disclosed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO disclosed